Influence of the chain length of ubiquinones on their interaction with DPPC in mixed monolayers

Biochimica et Biophysica Acta - Biomembranes

Volumn 1758, Issue 4, 2006, Pages 468-478

  Roche, Yann ^a   Peretti, Pierre ^a   Bernard, Sophie ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Fluorescence microscopy; Miscibility; Mixed monolayer; Molecular interaction; Ubiquinone

Indexed keywords

DIPALMITOYLPHOSPHATIDYLCHOLINE; ISOPRENOID; LIPID; UBIQUINONE;

ARTICLE; COMPRESSION; ENERGY; FILM; FLUORESCENCE MICROSCOPY; ISOTHERM; MISCIBILITY; PRESSURE; PRIORITY JOURNAL;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; KINETICS; LIPOSOMES; MEMBRANE LIPIDS; MICROSCOPY, FLUORESCENCE; SURFACE PROPERTIES; UBIQUINONE;

EID: 33646810851     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2006.03.015     Document Type: Article

References (53)

1. Collins M.D. Analysis of isoprenoid quinones. In: Press A. (Ed). Methods in Microbiology vol. 18 (1985), Academic Press, London 329-363
2. Moss G.P. IUPAC-IUB Commission on Biochemical Nomenclature vol. 2002 (1973)
3. Crane F.L., Hatefi Y., Lester R.L., and Widmer C. Biochim. Biophys. Acta 25 (1957) 220-221
4. Morton R.A., Wilson G.M., Lowe J.S., and Leat. Biochem. J. 68 (1958)
5. Ernster L., and Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim. Biophys. Acta 1271 (1995) 195-204
6. Mitchell P. Protonmotive Q cycle. General formulation. FEBS Lett. 59 (1975) 137-139
7. Brandt U., and Trumpower B. The protonmotive Q cycle in mitochondria and bacteria. Crit. Rev. Biochem. Mol. Biol. 29 (1994) 165-197
8. Kaufmann H.P., and Garloff H. Pro- and antioxidants in fats. II. Naturally occurring antioxidants. 1, Fette, Seifen. Anstrichmittel 63 (1961) 334-344
9. Kagan V.E., Fabisiak J.P., and Quinn P.J. Coenzyme Q and vitamin E need each other as antioxidants. Protoplasma (2000) 11-18
10. Nohl H., Gille L., and Staniek K. The biochemical, pathophysiological, and medical aspects of ubiquinone function. Ann. N.Y. Acad. Sci. 854 (1998) 394-409
11. Crane F.L., and Navas P. The diversity of coenzyme Q function. Mol. Aspects Med. 18 (1997) S1-S6
12. Crane F.L. New functions for coenzyme Q. Protoplasma (2000) 127-133
13. Gomez-Diaz C., Barroso M.P., and Navas P. Plasma membrane coenzyme Q10 and growth control. Protoplasma (2000) 19-23
14. Alleva R., Tomasetti M., Andera L., Gellert N., Borghi B., Weber C., Murphy M.P., and Neuzil J. Coenzyme Q blocks biochemical but not receptor-mediated apoptosis by increasing mitochondrial antioxidant protection. FEBS Lett. 503 (2001) 46-50
15. Kagan T., Davis C., Lin L., and Zakeri Z. Coenzyme Q10 can in some circumstances block apoptosis, and this effect is mediated through mitochondria. Ann. N.Y. Acad. Sci. 887 (1999) 31-47
16. Sobreira C., Hirano M., Shanske S., Keller R.K., Haller R.G., Davidson E., Santorelli F.M., Miranda A.F., Bonilla E., Mojon, et al. Mitochondrial encephalomyopathy with coenzyme Q10 deficiency. Neurology 48 (1997) 1238-1243
17. Rotig A., Appelkvist E.L., Geromel V., Chretien D., Kadhom N., Edery P., Lebideau M., Dallner G., Munnich A., Ernster, et al. Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet 356 (2000) 391-395
18. Boitier E., Degoul F., Desguerre I., Charpentier C., Francois D., Ponsot G., Diry M., Rustin P., and Marsac C. A case of mitochondrial encephalomyopathy associated with a muscle coenzyme Q10 deficiency. J. Neurol. Sci. 156 (1998) 41-46
19. Ihara Y., Namba R., Kuroda S., Sato T., and Shirabe T. Mitochondrial encephalomyopathy (MELAS): pathological study and successful therapy with coenzyme Q10 and idebenone. J. Neurol. Sci. 90 (1989) 263-271
20. Musumeci O., Naini A., Slonim A.E., Skavin N., Hadjigeorgiou G.L., Krawiecki N., Weissman B.M., Tsao C.Y., Mendell J.R., Shanske, et al. Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology 56 (2001) 849-855
21. Langsjoen, P. (1994).
22. Ruuge E.K., Kashkarov K.P., Lakomkin V.L., Timoshin A.A., and Vasil'eva E.V. The redox state of coenzyme Q10 in mitochondrial respiratory chain and oxygen-derived free radical generation in cardiac cells. Mol. Aspects Med. 18 (1997) s41-s50
23. Sinatra S.T. Refractory congestive heart failure successfully managed with high dose coenzyme Q10 administration. Mol. Aspects Med. 18 (1997) s299-s305
24. Linnane A.W., Degli Esposti M., Generowicz M., Luff A.R., and Nagley P. The universality of bioenergetic disease and amelioration with redox therapy. Biochim. Biophys. Acta 1271 (1995) 191-194
25. Linnane A.W., Kovalenko S., and Gingold E.B. The universality of bioenergetic disease. Age-associated cellular bioenergetic degradation and amelioration therapy. Ann. N.Y. Acad. Sci. 854 (1998) 202-213
26. Gingold E.B., Kopsidas G., and Linnane A.W. Coenzyme Q10 and its putative role in the ageing process. Protoplasma (2000) 24-32
27. Lerman-Sagie T., Rustin P., Lev D., Yanoov M., Leshinsky-Silver E., Sagie A., Ben-Gal T., and Munnich A. Dramatic improvement in mitochondrial cardiomyopathy following treatment with idebenone. J. Inherit. Metab. Dis. 24 (2001) 28-34
28. Helfenbaum L., Ngo A., Ghelli A., Linnane A.W., and Degli Esposti M. Proton pumping of mitochondrial complex I: differential activation by analogs of ubiquinone. J. Bioenerg. Biomembranes 29 (1997) 71-80
29. Degli Esposti M., Ngo A., McMullen G.L., Ghelli A., Sparla F., Benelli B., Ratta M., and Linnane A.W. The specificity of mitochondrial complex I for ubiquinones. Biochem. J. 313 Pt 1 (1996) 327-334
30. Miyoshi H. Probing the ubiquinone reduction site in bovine mitochondrial complex I using a series of synthetic ubiquinones and inhibitors. J. Bioenerg. Biomembranes 33 (2001) 223-231
31. Bernard S., Roche Y., Etienne F., and Peretti P. Interaction between ubiquinones and dipalmitoylphosphatidylcholine in mixed Langmuir monolayers. Mol. Cryst. Liquid Cryst. Sci. Technol., Sect. A Mol. Cryst. Liquid Cryst. 338 (2000) 207-221
32. Ulrich E.L., Girvin M.E., Cramer W.A., and Markley J.L. Biochemistry 24 (1985) 2501-2508
33. Metz G., Howard K.P., van Liemt W.B.S., Prestegard J.H., Lugtenburg J., and Smith S.O. J. Am. Chem. Soc. 117 (1995) 564-565
34. Alonso A., Gomez-Fernandez J.C., Aranda F.J., Belda F.J.F., and Goni F.M. On the interaction of ubiquinones with phospholipid bilayers. FEBS Lett. 132 (1981) 19-22
35. Katsikas H., and Quinn P.J. The polyisoprenoid chain length influences the interaction of ubiquinones with phospholipid bilayers. Biochim. Biophys. Acta (BBA), Biomembr. 689 (1982) 363-369
36. Jemiola-Rzeminska M., Mysliwa-Kurdziel B., and Strzalka K. The influence of structure and redox state of prenylquinones on thermotropic phase behaviour of phospholipids in model membranes. Chem. Phys. Lipids 114 (2002) 169-180
37. Jemiola-Rzeminska M., Kruk J., Skowronek M., and Strzalka K. Location of ubiquinone homologues in liposome membranes studied by fluorescence anisotropy of diphenyl-hexatriene and trimethylammonium-diphenyl-hexatriene. Chem. Phys. Lipids 79 (1996) 55-63
38. Lenaz G., Samori B., Fato R., Battino M., Parenti Castelli G., and Domini I. Localization and preferred orientations of ubiquinone homologs in model bilayers. Biochem. Cell. Biol. 70 (1992) 504-514
39. Samori B., Lenaz G., Battino M., Marconi G., and Domini I. On coenzyme Q orientation in membranes: a linear dichroism study of ubiquinones in a model bilayer. J. Membr. Biol. 128 (1992) 193-203
40. Hauss T., Dante S., Haines T.H., and Dencher N.A. Localization of coenzyme Q10 in the center of a deuterated lipid membrane by neutron diffraction. Biochim. Biophys. Acta (BBA), Bioenerg. 1710 (2005) 57-62
41. Hauss T., Dante S., Dencher N.A., and Haines T.H. Squalane is in the midplane of the lipid bilayer: implications for its function as a proton permeability barrier. Biochim. Biophys. Acta (BBA), Bioenerg. 1556 (2002) 149-154
42. Quinn P.J., and Esfahani M.A. Ubiquinones have surface-active properties suited to transport electrons and protons across membranes. Biochem. J. 185 (1980) 715-722
43. Sharma S., and Radhakrishnan T.P. Phospholipid-fatty acid composite monolayers: analysis of the pressure-area isotherms. Thin Solid Films 382 (2001) 246-256
44. Wu S. Intermolecular interaction in some mixed polymer monolayers at the air-water interface. J. Colloid Interface Sci. 29 (1969) 139-147
45. Dynarowicz-Latka P., and Kita K. Molecular interaction in mixed monolayers at the air/water interface. Adv. Colloid Interface Sci. 79 (1999) 1-17
46. Gaines G.L.J. In: Prigogine I. (Ed). Interscience Monographs on Physical Chemistry (1966), John Wiley and Son Inc
47. Jones M.N., and Chapman D. Micelles, Monolayers and Biomembranes (1995.), Wiley-Liss, Inc.
48. Goodrich F.C. International Congress of Surface Activity (1957) 8591
49. Lenaz G. Quinone specificity of Complex I. Biochim. Biophys. Acta (BBA), Bioenerg. 1364 (1998) 207-221
50. Jemiota-Rzeminska M., Latowski D., and Strzalka K. Incorporation of plastoquinone and ubiquinone into liposome membranes studied by HPLC analysis. The effect of side chain length and redox state of quinone. Chem. Phys. Lipids 110 (2001) 85-94
51. Heikkila R., Kwong C., and Cornwell D. Stability of fatty acid monolayers and the relationship between equilibrium spreading pressure, phase transformation, and polymorphic crystal form. J. Lipid Res. 11 (1970) 190-194
52. Petty M.C. Langmuir-Blodgett Films, an Introduction (1996), Cambridge University Press
53. Lenaz G. A critical appraisal of the mitochondrial coenzyme Q pool. FEBS Lett. 509 (2001) 151-155